Israel Active

Researchers from Israel’s Bar-Ilan University have produced tiny diamonds that can deliver medicinal and cosmetic treatments to cells, through layers of human skin. They are also effective antioxidants. The nano-diamonds are produced by detonating explosives inside a closed chamber. -

Researchers at Jerusalem’s Hadassah Medical Organization have developed an AI algorithm to identify, with 96% accuracy, all possible harmful mutations of the TP53 cancer-causing gene. The breakthrough can improve genetic screening and customized treatment for cancer patients.

Researchers at Israel’s Bar-Ilan University have developed nanotechnology that prevents tumors from disabling the body’s Natural Killer (NK) cells. They used RNA molecules to stop the NK cells from expressing the gene that the tumor attacks. The NK cell is then free to destroy the tumor.

An international team of researchers led by Israel’s Weizmann Institute, has used bacteriophages (good viruses) to kill inflammation-causing gut bacteria that cause inflammatory bowel diseases (IBD) such as Ulcerative Colitis and Crohn’s. “Good” bacteria are not harmed.

Tel Aviv and Haifa University researchers have discovered Post Traumatic Stress Disorder (PTSD) sufferers share a similar microbial picture in their saliva. It can help future diagnosis of PTSD and may even lead to micro-biotic-related therapies.

Israel’s Synchrony Medical has developed LibAirty™ - a wearable vest that applies chest compressions on the patient's thorax which is synchronized with the patient's breathing cycle. It was conceived during the pandemic when patients with chronic lung conditions stopped coming to hospitals for treatment.

Israel’s HeartPoint Global has developed a stent for patients with congenital heart conditions. The HeartPoint Global Implant System (HPGS) regulates the flow of blood coming in and out of the heart. For children, fixing the blood flow and pressure can heal the heart without surgery.

Israeli biotech Short Wave Pharma is to conduct a clinical trial of its novel treatment for anorexia nervosa at Israel’s Sheba Medical Center for Eating Disorders. The phase II study of psilocybin-assisted psychotherapy is the first of its kind in Israel.

Israel’s Sheba Medical Center is partnering Opgal, a subsidiary of Israel’s Elbit Systems, to repurpose thermal imaging technologies previously reserved for military and security purposes. Energy and heat analysis can reveal many physiological processes in the body.

Hadassah-University Medical Center in Jerusalem’s Ein Kerem recently performed 6 liver and 6 kidney transplants in less than 14 days – a record for an Israeli hospital. The transplants were led by Israeli Arab Dr. Abed Khalaileh, Israelis’ altruistic kidney donations are also at a record level.